Monday, October 15, 2012
NIH research shows exercise as key in reducing body fat while preserving muscle
Exercise and healthy eating reduce body fat and preserve muscle in adults better than diet alone, according to a study funded and conducted by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the National Institutes of Health.
Monday, October 15, 2012
A bacterial protein in common house dust may worsen allergic responses to indoor allergens, according to research conducted by the National Institutes of Health and Duke University. The finding is the first to document the presence of the protein flagellin in house dust, bolstering the link between allergic asthma and the environment.
Saturday, October 13, 2012
Andrew Holmes, Ph.D., chief of the Laboratory of Behavioral and Genomic Neuroscience at the National Institute on Alcohol Abuse and Alcoholism (NIAAA), part of the National Institutes of Health, has been selected as the 2012 recipient of the Jacob P. Waletzky Award from the Society for Neuroscience. The $25,000 prize is given in recognition of innovative research into substance abuse and the brain and nervous system.
Friday, October 12, 2012
A free source of evidence-based information for health care professionals and for researchers studying liver injury associated with prescription and over-the-counter drugs, herbals, and dietary supplements is now available from the National Institutes of Health. Researchers and health care professionals can use the LiverTox database to identify basic and clinical research questions to be answered and to chart optimal ways to diagnose and control drug-induced liver injury.
Thursday, October 11, 2012
Results may help improve drugs for neurological disorders
Researchers have published the first highly detailed description of how neurotensin, a neuropeptide hormone which modulates nerve cell activity in the brain, interacts with its receptor. Their results suggest that neuropeptide hormones use a novel binding mechanism to activate a class of receptors called G-protein coupled receptors (GPCRs).
Tuesday, October 9, 2012
NIH-supported study first to show reduced risk solely through dietary modification
By sticking to a healthy diet in the years after pregnancy, women who develop diabetes during pregnancy can greatly reduce their risk of developing type 2 diabetes, a study supported by the National Institutes of Health has found.
Thursday, October 4, 2012
NIH network study first to compare oral medication, botox for type of incontinence
Oral medication for treating a type of incontinence in women is roughly as effective as Botox injections to the bladder, reported researchers who conducted a National Institutes of Health clinical trials network study, with each form of treatment having benefits and limitations.
Tuesday, October 2, 2012
GuLF STUDY makes final call for study participants
Time is running out for workers and volunteers who helped with the 2010 Deepwater Horizon oil spill cleanup to enroll in a long-term study of the possible effects of the oil spill on human health. The National Institute of Environmental Health Sciences (NIEHS), which is conducting the study, is seeking anyone who helped with the oil spill cleanup in any capacity to call and enroll. Enrollment in the GuLF STUDY (Gulf Long-term Follow-up Study) will close soon and would-be participants have until the end of December 2012 to sign up.
Monday, October 1, 2012
NIH study reveals multiple mechanisms may play role in complex disorder
Researchers investigating a known gene risk factor for Alzheimer’s disease discovered it is associated with lower levels of beta amyloid — a brain protein involved in Alzheimer's — in cognitively healthy older people. The findings suggest that a mechanism other than one related to beta amyloid accumulation may influence disease risk associated with the gene.
Thursday, September 27, 2012
Scientists may have discovered why a protein called MYC can provoke a variety of cancers. Like many proteins associated with cancer, MYC helps regulate cell growth. A study carried out by researchers at the National Institutes of Health and colleagues found that, unlike many other cell growth regulators, MYC does not turn genes on or off, but instead boosts the expression of genes that are already turned on.